Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy

BACKGROUND: The activation of the renin-angiotensin system (RAS) promotes tumor progression. In this study, we aimed to assess whether RAS inhibitors (RASIs) could improve the outcome of hepatocellular carcinoma (HCC) patients with primary hypertension after curative liver resection. METHODS: Data o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Feng, Long-Hai, Sun, Hui-Chuan, Zhu, Xiao-Dong, Zhang, Shi-Zhe, Li, Kang-Shuai, Li, Xiao-Long, Li, Yan, Tang, Zhao-You
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990038/
https://ncbi.nlm.nih.gov/pubmed/32042755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.11.131
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados